Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Tsochatzis

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2026
Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant CandidatesManuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar, et al.
Aging Cell|May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in MulticohortsZhiyu Wu, Shanshan Wu, Shuyao Song, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2026
Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant CandidatesManuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar, et al.
Aging Cell|May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in MulticohortsZhiyu Wu, Shanshan Wu, Shuyao Song, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Journal of Hepatology|January 24, 2026
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosisBenedikt Silvester Hofer, Marta Tonon, Laura Buttler, et al.
JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Pageof 16